Product Information
TRIFLURIDINE 1% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $23.0221 per ML under NDC 61314004475. Its NADAC has been published 647 times since Nov 28, 2013.
FDA first approved this application on Oct 6, 1995. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/mL
Manufacturer
Sandoz Inc.NDC
61314004475
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TRIFLURIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA074311FDA Approved
10/6/1995
TE Code
AT
On Market Since
5/14/2001
Pharmacological Classes
Price Statistics
The NADAC for TRIFLURIDINE 1% EYE DROPS has been published 647 times since Nov 28, 2013, and over the history we have for it it has risen 33.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.0221 per ML |
|---|---|
| All-time high | $24.0303 (Aug 12, 2026) |
| All-time low | $14.8240 (Nov 22, 2017) |
| 52-week high | $24.0303 |
| 52-week low | $21.5902 |
| Median price | $20.3972 |
| Average price | $19.9538 |
| Largest weekly change | +30.6% (Oct 17, 2018) |
| Weeks tracked | 647 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the trifluridine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
trifluridine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nucleoside Analog Antiviral class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIFLURIDINE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for TRIFLURIDINE 1% EYE DROPS, manufactured by Sandoz Inc., is $23.0221 per ML (NDC 61314004475), effective Sep 30, 2026.
How has the price of TRIFLURIDINE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for TRIFLURIDINE 1% EYE DROPS has risen 33.5%. It has been tracked across 647 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIFLURIDINE 1% EYE DROPS?
Since Nov 28, 2013, the NADAC for TRIFLURIDINE 1% EYE DROPS has ranged from a low of $14.8240 (Nov 22, 2017) to a high of $24.0303 (Aug 12, 2026), with a median of $20.3972 per ML.
Are there cheaper alternatives to TRIFLURIDINE 1% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of TRIFLURIDINE 1% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIFLURIDINE 1% EYE DROPS?
TRIFLURIDINE 1% EYE DROPS (NDC 61314004475) is labeled by Sandoz Inc., and CMS classifies it as a generic product.